We analysed by immunohistochemistry the expression of p53 protein in a case of micro-invasive carcinoma of the conjunctiva. About 50% of tumor cells showed a strong nuclear positivity for p53. This suggests that p53 gene alterations play a role in the development of this type of tumor.
DeppertW., Buschhausen-DenkerG., PatschinskyT., StienmeyerK.Cell cycle control of p53 in normal (3T3) and chemically trasformed (Meth A) mouse cells II. Requirement for cell cycle progression.Oncogene1990; 5: 1701–06.
5.
FinlayC.A., HindsP.W., LevineA.J.The p53 proto-oncogene can act as a suppressor of transformation.Cell1989; 57: 1083–93.
6.
NigroJ.M., BakerS.J., PreisingerA.C.. Mutations in the p53 gene occur in disease human tumor types.Nature1989; 342: 705–8.
7.
IggoR., GatterK., BartekJ., LaneD., HarrisA.L.Increased expression of mutant forms of p53 oncogene in primary lung cancer.Lancet1990; 335: 675–9.
CattorettiG., RulkerF., AndreolaS., D'AmatoL., DeliaD.p53 expression in breast cancer.Int J Cancer1988; 41: 178–83.
10.
IggoR., GatterK., BartekJ., LaneD., HarrisA.L.Increased expression of mutant forms of p53 oncogene in primary lung cancer.Lancet1990; 335: 675–9.
11.
MasudaH., MillarC., KoefferH.P., BattiforaH., ClineM.J.Rearrangement of the p53 gene in human osteogenetic sarcomas.Proc Natl Acad Sci USA1987; 84: 7716–9.
12.
EllisonD., GatterK., SteartP., LaneD., WellerR.Expression of the p53 protein in a spectrum of astrocytic tumors.J Pathol1992; 168: 383–6.
13.
SoiniY., VähäkangasK., NuorvaK., KamelD., LaneD., PääkköP.p53 immunohistochemistry in malignant fibrous histiocytomas and other mesenchymal tumors.J Pathol1992; 168: 29–33.
14.
NuorvaK., SoiniY., KamelD.. Concurrent p53 expression in bronchial dysplasias and squamous cell lung carcinomas.Am J Pathol1993; 142: 1–8.
15.
GustersonB.A., AnbazhaganR., WarrenW.. Expression of p53 in premalignant and malignant squamous epithelium.Oncogene1991; 6: 1785–9.
